Mirion Technologies (NYSE:MIR – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.370-0.420 for the period, compared to the consensus earnings per share estimate of 0.390. The company issued revenue guidance of $840.9 million-$857.0 million, compared to the consensus revenue estimate of $848.3 million. Mirion Technologies also updated its FY24 guidance to $0.37-$0.42 EPS.
Analyst Ratings Changes
Several brokerages recently commented on MIR. Citigroup upped their price target on shares of Mirion Technologies from $13.00 to $14.00 and gave the stock a buy rating in a research report on Monday, April 8th. TheStreet raised shares of Mirion Technologies from a d rating to a b- rating in a research report on Wednesday, February 14th.
Check Out Our Latest Report on Mirion Technologies
Mirion Technologies Trading Down 1.5 %
Mirion Technologies (NYSE:MIR – Get Free Report) last released its quarterly earnings data on Tuesday, February 13th. The company reported $0.12 earnings per share (EPS) for the quarter. Mirion Technologies had a negative net margin of 12.01% and a positive return on equity of 3.09%. The company had revenue of $230.40 million during the quarter.
Insider Transactions at Mirion Technologies
In other news, CFO Brian Schopfer sold 90,910 shares of the stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $11.00, for a total value of $1,000,010.00. Following the completion of the sale, the chief financial officer now owns 211,167 shares of the company’s stock, valued at $2,322,837. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 2.57% of the company’s stock.
Mirion Technologies Company Profile
Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.
Featured Stories
- Five stocks we like better than Mirion Technologies
- How to Evaluate a Stock Before Buying
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Why Are Stock Sectors Important to Successful Investing?
- Hilton Demonstrates Asset Light is Right for Investors
- 3 Healthcare Dividend Stocks to Buy
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Mirion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.